Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CLS Holdings rental income falls in H1, halves interim dividend

(Sharecast News) - Property investor CLS Holdings reported a mixed first-half performance on Wednesday, with progress on strategic priorities tempered by weaker rental income. Net rental income fell 9.5% year-on-year to £53.3m, reflecting the impact of property disposals and expiries, though CLS said this was partly offset by stronger income from new lettings and renewals. Lettings, on the other hand, rose 17% year-on-year, with management highlighting that momentum had accelerated post-period end.

EPRA earnings per share dropped 16.7% to 4.0p, while statutory losses per share from continuing operations narrowed 6.1p, down from 15.4p a year earlier. As a result, CLS cut its interim dividend in half to 1.30p per share, with the group citing a more disciplined capital allocation approach.

CLS also said it had completed or exchanged contracts on property sales worth £143m during the half, helping reduce leverage and meet refinancing targets. However, EPRA net tangible assets per share declined 2.6% to 209.5p, and statutory NAV per share fell 2.5% to 192.3p.

CEO Fredrik Widlund said: "We continue to make progress reshaping the business, creating a more focused portfolio of higher-quality, faster-growing properties to drive earnings growth.

"We enter the second half with clear strategic direction and cautious optimism, supported by improving market fundamentals, a robust leasing environment and a somewhat more stable macroeconomic outlook."

As of 0805 BST, CLS shares were up 1.42% at 64.20p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.